Intervention

NX-1607

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting1

Common conditions14

Lead sponsors shown1

Clinical trials

1 shown

A Study of NX-1607 in Adults With Advanced MalignanciesNCT05107674 · 2021-09-29

RECRUITING

Common conditions

Cervical Cancer1 Diffuse Large B Cell Lymphoma (DLBCL)1 Gastric Cancer1 GastroEsophageal Junction (GEJ) Cancer1 Head and Neck Squamous Cell Carcinoma1 Malignant Pleural Mesothelioma (MPM)1 Metastatic Castration-resistant Prostate Cancer (mCRPC)1 Metastatic or Unresectable Melanoma1 Metastatic Urothelial Carcinoma1 Microsatellite Stable Colorectal Carcinoma1 Non-small Cell Lung Cancer (NSCLC)1 Ovarian Cancer, Epithelial1 Richter Transformation1 Triple Negative Breast Cancer (TNBC)1

Leading sponsors

Nurix Therapeutics, Inc.1

Trial status mix

RECRUITING1

Phase mix

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.